Cardio Industry Executive Ed Rieflin Appointed to Chair Vvital Biomed
Cardio Industry Executive Ed Rieflin Appointed to Chair Vvital Biomed USA - English News provided by Share this article ("Vvital"), a portfolio company of The Trendlines Group (SGX: 42T) (OTCQX: TRNLY), announced the appointment of Ed Rieflin as Chair of the Board. Ed brings 19 years of executive leadership experience and success from Thoratec, St. Jude Medical and Abbott Laboratories, where he served as Senior Vice President of Heart Failure. Commenting on the appointment Rieflin said, "Long-term treatment solutions to mitral valve regurgitation are the holy grail of this sector. Vvital's ap...
Source: prnewswire.com